GlucoTrack amends stock purchase agreement with White Lion Capital

GlucoTrack, Inc. entered into an amendment to its Common Stock Purchase Agreement with White Lion Capital, LLC on August 7, 2026, according to an 8-K filed with the SEC. The agreement being amended, known as the ELOC Purchase Agreement, was originally dated July 14, 2026.¹

The amendment revises how GlucoTrack calculates the commitment shares it owes to White Lion. Under the change, the company will issue 2,505,513 shares of common stock to the investor within one business day after the resale registration statement becomes effective, with the share count derived by dividing a $1,000,000 commitment fee by the agreement's defined Minimum Price.¹

The amendment also introduces a new provision addressing a scenario where the commitment fee price comes in below that minimum. If the Commitment Fee Price ends up lower than the Minimum Price, GlucoTrack will owe White Lion a true-up payment, set at $1,000,000 less the value of 2,505,513 shares multiplied by the Commitment Fee Price.¹ That true-up amount, if owed, must be paid within 120 days following the agreement's defined Measurement Date.¹ No payment is required if the Commitment Fee Price meets or exceeds the Minimum Price.¹

All other terms of the original ELOC Purchase Agreement remain unchanged.¹ The commitment shares will be issued under exemptions from securities registration requirements provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.¹ The filing was signed by Chief Executive Officer Erik Emerson and dated August 10, 2026.